{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:08:14Z","timestamp":1760015294462,"version":"3.38.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.jpba.2011.01.044","type":"journal-article","created":{"date-parts":[[2011,2,7]],"date-time":"2011-02-07T09:11:22Z","timestamp":1297069882000},"page":"342-348","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of pharmacokinetic and pharmacodynamic relationship for oral sustained-release atenolol pellets in rats"],"prefix":"10.1016","volume":"55","author":[{"given":"Junting","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chendong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanxia","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2011.01.044_bib0005","first-page":"66","article-title":"Long-term stability characterization of a controlled release gastrointestinal therapeutic system coated with a cellulose acetate pseudolatex","volume":"56","author":"Vaithiyalingam","year":"2001","journal-title":"Pharmazie"},{"key":"10.1016\/j.jpba.2011.01.044_bib0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-3659(96)01553-2","article-title":"Atenolol gastrointestinal therapeutic system: optimization of formulation variables using response surface methodology","volume":"45","author":"Sastry","year":"1997","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpba.2011.01.044_bib0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2125.1985.tb05072.x","article-title":"A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects, Br","volume":"20","author":"Rigby","year":"1985","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2011.01.044_bib0020","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0149-2918(08)80053-7","article-title":"Pharmacokinetic and pharmacodynamic characteristics of aranidipine sustained-release, enteric-coated tablets in healthy Chinese men: a Phase I, randomized, open-label, single- and multiple-dose study","volume":"30","author":"Jiang","year":"2008","journal-title":"Clin Ther."},{"key":"10.1016\/j.jpba.2011.01.044_bib0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0031-6865(97)00052-6","article-title":"Aqueous based polymeric dispersion: Plackett\u2013Burman design for screening of formulation variables of atenolol gastrointestinal therapeutic system","volume":"73","author":"Sastry","year":"1998","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/j.jpba.2011.01.044_bib0030","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/10837459809028623","article-title":"Aqueous-based polymeric dispersion: face-centered cubic design for the development of atenolol gastrointestinal therapeutic system","volume":"3","author":"Sastry","year":"1998","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jpba.2011.01.044_bib0035","first-page":"639","article-title":"Preparation and evaluation of mucoadhesive microspheres of atenolol and propranolol","volume":"1","author":"Patil","year":"2009","journal-title":"Int. J. Pharm. Technol. Res."},{"key":"10.1016\/j.jpba.2011.01.044_bib0040","doi-asserted-by":"crossref","DOI":"10.1208\/pt070103","article-title":"Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology","volume":"7","author":"Singh","year":"2006","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jpba.2011.01.044_bib0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2003.12.004","article-title":"Controlled release of atenolol from the ethylenevinyl acetate matrix","volume":"273","author":"Kim","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpba.2011.01.044_bib0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jscs.2010.02.014","article-title":"Controlled release of atenolol from freeze\/thawed poly(vinyl alcohol) hydrogel","volume":"14","author":"Kenawy","year":"2010","journal-title":"J. Saudi Chem. Soc."},{"key":"10.1016\/j.jpba.2011.01.044_bib0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0928-0987(02)00223-3","article-title":"Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release","volume":"18","author":"Streubel","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2011.01.044_bib0060","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0031-6865(97)00050-2","article-title":"Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25mg atenolol","volume":"73","author":"Rouge","year":"1998","journal-title":"Pharm. Acta Helv."},{"key":"10.1016\/j.jpba.2011.01.044_bib0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejpb.2006.04.004","article-title":"Preparation and in vitro\/in vivo evaluation of sustained-release metformin hydrochloride pellets","volume":"64","author":"Hu","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jpba.2011.01.044_bib0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0169-409X(98)00027-1","article-title":"Pharmacodynamic aspects of sustained release preparations","volume":"33","author":"Hoffman","year":"1998","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.jpba.2011.01.044_bib0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2165\/00003088-199426020-00006","article-title":"Influence of drug formulation on drug concentration\u2013effect relationships","volume":"26","author":"Castaneda-Henandez","year":"1994","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jpba.2011.01.044_bib0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/jps.1167","article-title":"Pharmacokinetic\/pharmacodynamic studies in drug product development","volume":"91","author":"Meibohm","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jpba.2011.01.044_bib0085","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0022-3565(24)38301-6","article-title":"A pharmacokinetic\/pharmacodynamic model for recombinant human growth hormone effects on induction of insulin-like growth factor I in monkeys","volume":"289","author":"Sun","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jpba.2011.01.044_bib0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2165\/00003088-199121050-00001","article-title":"Controlled release metoprolol: clinical pharmacokinetic and therapeutic implications","volume":"21","author":"Kendall","year":"1991","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jpba.2011.01.044_bib0095","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0188-4409(00)00242-3","article-title":"Pharmacokinetic\u2013pharmacodynamic modeling: why?","volume":"31","author":"Perez-Urizar","year":"2000","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.jpba.2011.01.044_bib0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.amjcard.2006.07.015","article-title":"Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension","volume":"98","author":"Henderson","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jpba.2011.01.044_bib0105","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.pbb.2006.09.016","article-title":"Nociceptive stimulus modality-related difference in pharmacokinetic\u2013pharmacodynamic modeling of morphine in the rat","volume":"85","author":"Shang","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jpba.2011.01.044_bib0110","first-page":"231","article-title":"Preparation of atenolol sustained-release pellets and its pharmacokinetics in rat","volume":"18","author":"Dong","year":"2010","journal-title":"Pharm. Clin. Res."},{"key":"10.1016\/j.jpba.2011.01.044_bib0115","first-page":"387","article-title":"Study on pharmacokinetics of atenolol tablets in old healthy volunteers and nephrotic patients","volume":"19","author":"Wang","year":"1998","journal-title":"Chin. Hosp. Pharm. J."},{"key":"10.1016\/j.jpba.2011.01.044_bib0120","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.vascn.2005.01.002","article-title":"Applicability of microdialysis as a technique for pharmacokinetic\u2013pharmacodynamic (PK\u2013PD) modeling of antihypertensive beta-blockers","volume":"52","author":"Hocht","year":"2005","journal-title":"J. Pharmacol. Toxicol."},{"key":"10.1016\/j.jpba.2011.01.044_bib0125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0278-6915(00)00136-8","article-title":"Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats","volume":"39","author":"Desesso","year":"2001","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.jpba.2011.01.044_bib0130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdd.2510160502","article-title":"Comparison of the gastrointestinal anatomy, physiology and biochemistry of humans and commonly used laboratory animals","volume":"16","author":"Kararli","year":"1995","journal-title":"Biopharm. Drug. Dispos."},{"key":"10.1016\/j.jpba.2011.01.044_bib0135","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/00970002042006007","article-title":"Pharmacokinetics and pharmacodynamics of extended-release glipizide GITS compared with immediate-release glipizide in patients with type II diabetes mellitus","volume":"42","author":"Chung","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jpba.2011.01.044_bib0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/bmj.291.6487.19","article-title":"Relief of pain by infusion of morphine after operation: does tolerance develop?","volume":"291","author":"Marshall","year":"1985","journal-title":"Br. Med. J. Clin. Res. Ed."},{"key":"10.1016\/j.jpba.2011.01.044_bib0145","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2165\/00003495-199141050-00006","article-title":"Sustained release nifedipine formulations: an appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders","volume":"41","author":"Murdoch","year":"1991","journal-title":"Drugs"},{"key":"10.1016\/j.jpba.2011.01.044_bib0150","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00210-006-0078-x","article-title":"Pharmacokinetic\u2013pharmacodynamic (PK\u2013PD) modeling of cardiovascular effects of metoprolol in spontaneously hypertensive rats: a microdialysis study","volume":"373","author":"Hocht","year":"2006","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.jpba.2011.01.044_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00210-004-0945-2","article-title":"Pharmacokinetic\u2013pharmacodynamic properties of metoprolol in chronic aortic coarctated rats","volume":"370","author":"Hocht","year":"2004","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.jpba.2011.01.044_bib0160","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/sj.bjp.0707234","article-title":"Pharmacokinetic\u2013pharmacodynamic modelling of S(\u2212)-atenolol in rats: reduction of isoprenaline-induced tachycardia as a continuous pharmacodynamic endpoint","volume":"151","author":"Steeg","year":"2007","journal-title":"Br. J. Pharmacol."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708511000707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708511000707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T12:18:10Z","timestamp":1740917890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708511000707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0731708511000707"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2011.01.044","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}